Epilepsy is a group of neurological disorders in which individuals are at risk for recurrent seizures. The diagnosis of epilepsy is defined as the occurrence of two or more unprovoked seizures during an individual’s lifetime. In the general population, about 1 in 10 (10%) will have one seizure during their lifetime and about 3% will be diagnosed with epilepsy.
There are a number of different causes for epilepsy, including genetic and non-genetic factors. Majority of epilepsy is caused by a combination of these factors, with most related to infection, stroke, head trauma, brain tumor, or brain malformation. Factors that impact whether an individual has an underlying genetic cause to their epilepsy include the type of seizure (partial, generalized, or other), age of onset, family history, and other clinical features such as intellectual disability, autism spectrum disorder, or congenital anomalies. An underlying genetic cause may be identified in 30-50% of those with epilepsy (this percent is variable depending on the population and other factors considered). The genetic causes may include chromosomal abnormalities or single gene disorders. The different causes may be de novo (new) or inherited in an autosomal dominant, autosomal recessive, X-linked, or mitochondrial pattern.
For those with epilepsy, particularly childhood onset, there are multiple types of genetic tests that may be considered. Recommendations may differ between patients depending on whether there are other clinical features present. Testing may include biochemical screening, chromosome microarray, single gene tests, multigene panels, or whole exome sequencing.
For those with other clinical features such as intellectual disability, autism spectrum disorder, or congenital anomalies, the chromosome microarray may be considered as a first tier test. The chromosome microarray is used to identify small missing or extra pieces of chromosome material, and can identify or rule out several hundred known genetic syndromes. This testing has a detection rate (the chance for the testing to come back positive) of about 20-30%. For all individuals with epilepsy the detection is less than 5%.
Further testing that may be considered includes single gene testing, multigene panel testing or whole exome sequencing which involves analysis of one, many, or all of our genes. About 15-40% of individuals with epilepsy are found to have a single gene disorder on one of these tests.
Genetic testing may be considered for those with epilepsy as the identified underlying genetic cause may impact the treatment of the individual. For instance, there may be indication or contraindication for a specific anti-epileptic drugs, a biochemical diagnosis that directs medication or dietary management, or other.
Learn more about scheduling a genetic counseling appointment.